Grants Search Results

This institution is a member of a research consortium, the Childhood and Adolescent Lymphoma Cell Therapy Consortium (CALCTC), which is named for Markit, Ltd. whose 24-hour head-shaving events worldwide have raised over $2.2 million since 2007 to fund life-saving research through the St. Baldrick’s Foundation. For a description of this project, see the consortium grant made to the lead institution: the New York Medical College - Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY.

This institution is a member of a research consortium, the Childhood and Adolescent Lymphoma Cell Therapy Consortium (CALCTC), which is named for Markit, Ltd. whose 24-hour head-shaving events worldwide have raised over $2.2 million since 2007 to fund life-saving research through the St. Baldrick’s Foundation. For a description of this project, see the consortium grant made to the lead institution: the New York Medical College - Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY.

This institution is a member of a research consortium, the Childhood and Adolescent Lymphoma Cell Therapy Consortium (CALCTC), which is named for Markit, Ltd. whose 24-hour head-shaving events worldwide have raised over $2.2 million since 2007 to fund life-saving research through the St. Baldrick’s Foundation. For a description of this project, see the consortium grant made to the lead institution: the New York Medical College - Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY.

This institution is a member of a research consortium, the Childhood and Adolescent Lymphoma Cell Therapy Consortium (CALCTC), which is named for Markit, Ltd. whose 24-hour head-shaving events worldwide have raised over $2.2 million since 2007 to fund life-saving research through the St. Baldrick’s Foundation. For a description of this project, see the consortium grant made to the lead institution: the New York Medical College - Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY.

This institution is a member of a research consortium, the Childhood and Adolescent Lymphoma Cell Therapy Consortium (CALCTC), which is named for Markit, Ltd. whose 24-hour head-shaving events worldwide have raised over $2.2 million since 2007 to fund life-saving research through the St. Baldrick’s Foundation. For a description of this project, see the consortium grant made to the lead institution: the New York Medical College - Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, NY.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Consortium for Pediatric Intervention Research. For a description of this project, "Pharmacologic prevention of heart failure in survivors of childhood cancer," see the consortium grant made to the lead institution: the Beckman Research Institute of the City of Hope, Duarte, CA. Year two of this grant was generously funded by the Rally Foundation.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Mechanisms Underlying DICER1 Suppression of Pleuropulmomary Blastoma Consortium. For a description of this project, see the consortium grant made to the lead institution: the Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

This institution's International PPB Registry is a member of a research consortium which is being funded by St. Baldrick's: the Mechanisms Underlying DICER1 Suppression of Pleuropulmomary Blastoma Consortium. For a description of this project, see the consortium grant made to the lead institution: the Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Mechanisms Underlying DICER1 Suppression of Pleuropulmomary Blastoma Consortium. For a description of this project, see the consortium grant made to the lead institution: the Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Mechanisms Underlying DICER1 Suppression of Pleuropulmomary Blastoma Consortium. For a description of this project, see the consortium grant made to the lead institution: the Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Ex vivo expanded hematopoietic progenitors for AML supportive care Clinical Trial Consortium. For a description of this project, see the consortium grant made to the lead institution: the Fred Hutchinson Cancer Research Cancer, Seattle, WA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Ex vivo expanded hematopoietic progenitors for AML supportive care Clinical Trial Consortium. For a description of this project, see the consortium grant made to the lead institution: the Fred Hutchinson Cancer Research Cancer, Seattle, WA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Ex vivo expanded hematopoietic progenitors for AML supportive care Clinical Trial Consortium. For a description of this project, see the consortium grant made to the lead institution: the Fred Hutchinson Cancer Research Cancer, Seattle, WA.

This institution is a member of a research consortium which is being funded by St. Baldrick's: the Texas-Oklahoma Pediatric Neuro-Oncology Consortium (TOPNOC). For a description of this project, "Comprehensive Studies of Pediatric CNS Tumors," see the consortium grant made to the lead institution: the Baylor College of Medicine, Texas Children's Hospital, Houston, TX.

Through this partnership with CanKids, the proceeds from St. Baldrick's events in India are used to fund childhood cancer research in India.

This grant is split between Nadezhda Lomakinal and Priya Borker to work in a pediatric oncology research lab for the summer after their first year of medical school. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds Eric Dybbro to work in a pediatric oncology research lab for the summer after the first year of medical school. The experience may encourage Eric to choose childhood cancer research as a specialty.